VC Directory

GROWTH AI VCs Directory

Curated index of active venture capital funds investing in Europe and Israel. Track partners, stages, and check sizes.

Oberland Capital Management

US

Oberland Capital is a private investment firm focused on providing structured financing solutions to companies within the global healthcare industry. They aim to accelerate the development and commercialization of promising healthcare products, creating value for their partners and improving patient care. Oberland Capital specializes in flexible investment structures tailored to the specific needs of its partners, including monetization of royalty streams, acquisition of future product revenues, project-based financing, and traditional debt and equity investments. The firm employs a fundamental, research-driven approach coupled with quantitative methods to identify and invest in innovative technologies. They focus on investing in pharmaceutical, biotechnology, medical device, and diagnostic companies, partnering with public and private entities, research institutions, and individual inventors. Oberland Capital works collaboratively with management teams to develop creative structures that meet their strategic and financial objectives, providing access to significant capital for various purposes, such as accelerating R&D, expanding commercial infrastructure, acquiring new assets, and refinancing existing capital sources. Oberland Capital distinguishes itself through its flexible investment structures, global transactional experience, and deep domain expertise. They have substantial experience in local legal, tax, and accounting frameworks, enabling them to deploy innovative structures tailored to each geography. The team's scientific, operational, and financial expertise allows them to design creative capital solutions that address the complexities of product development and commercialization across the life sciences sector. They offer meaningful scale, providing partners with $50 million to $300+ million to accelerate organic and inorganic growth opportunities. The firm’s investment strategy focuses on near-commercial stage biopharmaceutical companies with highly differentiated products and deep clinical pipelines, as well as companies with strong commercial products. They have a track record of creating value for their partners through their flexible investment structures and deep healthcare expertise.

Clinical-stage and commercial-stage companiespharmaceuticalsbiotechnology

Octerra Capital

CA

Octerra Capital is an African-led investment fund focused on investing in innovative early-stage tech solutions across the African continent. Their mission is to accelerate prosperity by empowering innovators who are driving Africa's transformation. They are sector-agnostic and focus on catalyzing economic growth by addressing challenges in financial inclusion, democratization of access, interconnectedness, and improving the quality of education and healthcare. The firm believes in the power of innovation and entrepreneurship to create solutions that will address the challenges that Africa faces and drive sustainable socio-economic growth. They invest in companies and individuals who share their values and are dedicated to creating sustainable, long-term value. Octerra Capital seeks high-growth tech startups with scalable solutions designed for the African continent that have launched their business and have initial traction. They also look for innovative technology or tech-enabled businesses that are impact-driven and have a strong and diverse founding team. Octerra Capital's investment approach is centered around a desire to catalyse economic growth by addressing challenges in financial inclusion, democratisation of access, interconnectedness and improving quality of education and healthcare. They are deeply passionate about Africa’s growth and firmly embedded in the African tech ecosystem.

Early-stageFinancial InclusionGender Inclusion

Octopus Energy Development Partnership (OEDP)

GB

Octopus Ventures invests in companies driving the transition to a cleaner, smarter, and more sustainable energy future. Focus areas include renewable energy generation, energy storage, smart grid technologies, electric vehicle infrastructure, and energy efficiency solutions. The firm supports innovative startups and scale-ups that are pivotal in reducing carbon emissions and accelerating the adoption of low-carbon technologies.

Early-stage to growth-stage companies in energy transition and sustainability sectors.Investment in renewable energy infrastructuresmart energy technologies

Octopus First Cheque Fund

London, GB

Octopus Ventures is a large and active venture capital investor in Europe, focusing on investing in people, ideas, and industries that are changing the world for the better. Their mission is to invest in areas where they can make the biggest impact: building a more sustainable planet, empowering people, and revitalizing healthcare. They aim to back entrepreneurs who are reimagining how whole industries behave, specifically those eliminating carbon footprints, creating cancer vaccines, building the next phase of the internet, and charting a greener approach to space travel. They aim to invest £10 billion in industries bringing about positive change by 2030. The firm seeks founders with purpose, building revolutionary solutions to change the world, with clear visions and focused on solving society’s biggest problems. They prioritize businesses that put people, community, and the environment first, investing as early as an idea on a page and supporting every growth stage with funding and hands-on support. Octopus Ventures also runs a mentorship program, matching founders and senior leaders with seasoned professionals from their network for knowledge and experience sharing. Octopus Ventures emphasizes diversity and inclusion, striving to welcome people from the widest range of backgrounds and experience into their team and portfolio companies. They acknowledge their leadership in investing in female leaders but recognize the need to do more to support everyone, regardless of culture, race, gender, orientation, or economic status. The firm invests across seven core areas to build long-lasting relationships with founders.

Pre-seed, Seed, Series A, Later StagesB2B SoftwareBio

Octopus Investments

London, GB

Octopus Group's investment thesis centers around backing people, ideas, and industries that will change the world. They aim to be a catalyst for positive, meaningful change by investing in disruptive and progressive companies. The group is comprised of entrepreneurs and investors, focusing on sectors like financial services, energy, and education. They believe in outbehaving the competition and prioritizing purpose over profit, which in turn drives sustainable growth. Octopus seeks to build companies that contribute positively to society and create lasting partnerships with investors.

Early StageFinancial servicesEnergy

Odyssey Ventures

London, GB

Odyssey Ventures focuses on bridging the valuation gap between European and US startups. They aim to capitalize on the disparity where European startups are often undervalued compared to their US counterparts, creating an opportunity for higher returns upon exit or further funding rounds that reflect US-level valuations. Their strategy appears to involve identifying promising early-stage European companies, providing them with not only capital but also strategic guidance and resources to help them scale and compete effectively in the global market. This approach includes supporting expansion efforts into the US market and facilitating connections with US investors and potential acquirers. Their $75M fund is likely deployed to facilitate the aforementioned strategy, targeting firms ripe for rapid growth.

Early-stageManufacturingChemicals

Odyssée Venture

FR

Odyssée Venture positions itself as a growth accelerator for ambitious French companies. They focus on providing capital and support to SMEs during periods of strong growth, such as new product launches, commercial expansion, internationalization, and external growth. Their approach is based on a close and transparent relationship with entrepreneurs, emphasizing open communication and quick decision-making. With a history dating back to 1999, they have financed nearly 200 French growth SMEs through various investment vehicles like FCPI, FIP, and FCPR, ranging from startups to pre-IPO companies. Odyssée Venture emphasizes collective intelligence and resilience in the companies they back. The firm aims to be a reliable partner, bringing experience and a unique philosophy to the investor-entrepreneur relationship.

Start-up to pre-IPOGrowth stage companiesSMEs

Olympia Group

GR
O

Olympia Group is an international investment group operating across 8 countries, driven by the pursuit of business excellence. Founded in 1980, the group emphasizes dedication, creativity, and a strong corporate philosophy. They combine deep industry expertise with local market experience to achieve growth. The Group operates under a modern corporate governance model and aims to enhance its activities and achieve successful growth in the future. The Olympia Group functions as a dynamic multinational organization. Their activities encompass various sectors and regions, suggesting a diversified investment approach. Their focus is on further expansion and success in all markets where they have a presence. They also emphasize the importance of corporate governance with a culture of transparency and inclusion where everyone feels valued and able to challenge and contribute. Olympia Group's strategy appears to be based on identifying opportunities where they can leverage their industry expertise and local market knowledge to create value. The group seeks to create a sustainable and successful organization, as highlighted by their high caliber professionals across 8 countries sharing knowledge, expertise, resources and learning opportunities. Their investment approach might be opportunistic, expanding their reach in a highly competitive environment.

Unclear from crawled pages, likely growth stage given company sizes in portfolioUnclear from crawled pages. Companies mentioned in portfolio hints at: RetailEnergy (Batteries)

OneVentures

AU

OneVentures is a later-stage Venture Capital Firm focused on scaling Technology and Healthcare companies through growth equity and credit. They position themselves as true business partners, providing expert advisors, analysts, and access to a global network. They aim to provide more than just capital, actively helping portfolio companies sharpen their development and commercialization strategies and forge connections with industry partners. The firm's approach is characterized by unyielding support, consultation, and input across many parts of the business, reflecting a partner who wants to do good while considering all aspects. They focus on transformative founders building for the future.

Later-stage, Growth EquityTechnologyHealthcare

Open Ocean Capital

London, GB

OpenOcean is a pan-European early-stage venture capital firm focused on investing in technical teams that are reshaping knowledge work and the infrastructure required to scale it. They target companies in the AI-native software, automation, and foundational technology sectors. The firm's roots are in building and scaling fundamental data software companies, and they leverage their experience as former operators and entrepreneurs to work closely with founders from early technical decisions to global scaling. Their strategy involves backing data-driven businesses built for long-term advantage. With a deep understanding of underlying technologies and software stacks, OpenOcean aims to identify and invest in category-winning startups at the early stages. Their expertise enables them to support companies with unique solutions that can be rapidly scaled and adopted globally. They are focused on partnering with technical founders shaping how humans and technology thrive together. They focus on companies driving the growth of innovative new digital platforms and services. OpenOcean emphasizes a strong technical background and global scaling expertise as key elements to identifying and investing in early-stage startups.

Early-stage, Series AAI-native softwareautomation

Openspace Ventures

Singapore, SG

Openspace Ventures is a multi-strategy asset manager focused on Southeast Asia, investing in tech-native and tech-enabled companies across multiple stages and product needs. With US$800M in committed capital across 6 funds, the firm targets early and growth-stage companies within various sectors. They emphasize using 'Active Intelligence' to work with portfolio companies, aiming to help them realize bolder visions and accelerate progress responsibly and viably. The firm's investment approach is driven by a deep understanding of the Southeast Asian market, leveraging a diverse team with varied experiences and an always-available operational team. They focus on bridging the climate funding gap in the region, actively investing in the emerging climate tech opportunity. Openspace combines a strong local presence, market understanding, and ecosystem partnerships to deliver value in this sector. They also have a focus on diversity within their own team and encourage work-life flexibility. Openspace aims to transform categories, lives, and culture through their investments. They partner with companies and offer expertise and experiences to help them grow from strength to strength. The firm states that they are always there to help their companies when and where they ask for it and partner with candour and good humour. They are also active in producing research and reports. The Coalesce Index, for example, measures the interconnectedness of Southeast Asia and provides key learnings for investors, founders, and observers in the region.

Early stage, growth stage, Series A, Series BTech-nativetech-enabled companies

Oras Invest

FI

Oras Invest is a Finnish family-owned investment company focused on long-term industrial ownership. Their strategy centers around developing companies within building, water, and bio-based materials value chains, as well as closely related sectors. They distinguish themselves from financial investors through an exceptionally long ownership horizon, spanning generations and decades, allowing for patient development and growth of their portfolio companies. With roots in family entrepreneurship, stemming from the faucet company Oras founded in 1945, they possess unique industrial expertise within their network. Their approach involves active board work and close cooperation with the management and other significant owners of their portfolio companies. This hands-on involvement aims to capitalize on the strengths and potential of each company, fostering sustainable growth and value creation. The firm's investment philosophy is anchored in a deep understanding of industrial businesses and a commitment to long-term value creation, rather than short-term financial gains. Oras Invest's current industrial ownerships include prominent companies such as Oras Group, Kemira, Valmet, Georg Fischer, Lindab, and Konecranes, demonstrating their focus on established, market-leading businesses. The net asset value of Oras Invest was EUR 1.7 billion at the end of 2024. Their investment strategy is clearly focused on established industrial players where they can exert influence through significant ownership stakes. They appear to favor companies with a strong market position, global reach, and a focus on sustainable solutions. The inclusion of companies like Kemira (sustainable chemical solutions), Valmet (pulp, paper, and energy industries), and Lindab (energy-efficient ventilation) suggests an interest in environmentally conscious and resource-efficient businesses. The firm’s commitment is reflected in their annual reviews which give insight into the development of their NAV and ownerships.

Not explicitly stated, but appears to be focused on established, mature industrial companies with significant revenue and market share, not early stage venture.Building materialswater

Orbimed Advisors

New York, US

OrbiMed is a global investment firm focused on the healthcare industry. They aim to invest in world-class healthcare companies to drive innovation, address unmet medical needs, and improve patient outcomes. They focus on long-term growth trends led by global demographics and scientific innovation in treating disease. OrbiMed believes the healthcare industry's powerful growth profile, coupled with its magnitude and complexity, creates numerous investment opportunities. Their investment strategy is broad and flexible, covering the global healthcare industry from seed-stage venture capital to large publicly-traded companies. They invest through public equity, private equity, and private credit/royalty strategies. In private equity, OrbiMed often acts as a lead investor, actively helping portfolio companies to become market leaders, with a global investment scope including North America, Asia, and Europe. They also offer non-dilutive structured debt capital and royalty monetization solutions to commercial-stage healthcare companies and intellectual property owners. OrbiMed invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services. They seek companies focused on responsible, sustainable growth to build long-term shareholder value. They have been investing globally for over 25 years and currently manage approximately $20 billion across public and private company investments worldwide.

Seed-stage, venture capital, start-ups, growth equity, commercial-stage companies, early-stage, late-stage, pre-IPOBiopharmaceutical productsmedical technologies

Orbit Capital

Czech Republic

Orbit Capital is a venture capital firm focused on growing innovative scale-ups. Their investment strategy centers around championing tech and tech-enabled SMEs and Small Mid Caps into lasting enterprises. They aim to be trusted, value-adding partners to ambitious entrepreneurs, offering experience, ambition, and rigor to support their portfolio companies' growth. The firm seeks companies that have demonstrated resilience in their home market, boast a recurring or strong customer base, and exhibit healthy margins based on global benchmarks, coupled with strong unit economics. They prioritize companies with a minimum run rate of EUR 8M and a growth rate of at least 30% per annum. Orbit Capital's approach appears to be hands-on, emphasizing partnership and value addition. They aim to build a portfolio of champion companies, reflecting a long-term commitment to fostering sustainable growth and positive outcomes for both the companies they invest in and their own stakeholders. The firm values meritocracy, curiosity, commitment, and respect. They are always rising aspirations, fostering a "positive sum" principle, building to last, caring, and radically honest.

Scaling / expansionTechtech-enabled

Orion Infrastructure Capital (OIC)

US

Orion Infrastructure Capital (OIC) invests in environmentally and socially innovative infrastructure companies. The firm believes that infrastructure must evolve to address the challenges of generating power, sustaining agriculture, and managing waste, and sees significant opportunity in companies driving this transition. OIC focuses on building collaborative investment partnerships with private businesses, particularly middle market companies and entrepreneurs, that are developing and scaling critical infrastructure solutions. Their goal is to generate strong financial returns for their investors while also creating beneficial outcomes for society, emphasizing responsible investment principles that integrate value creation, risk mitigation, and profitability. OIC aims to bridge the gap between current infrastructure and the infrastructure of tomorrow by providing creative credit, equity, and growth capital solutions. They position themselves as more than just a source of capital, actively collaborating with their partner companies to transform ideas into action and drive long-term value. The firm prioritizes partnerships with companies that can catalyze positive change across infrastructure, energy, and industrial ecosystems, acting as relentless problem solvers to identify and capitalize on opportunities that others may overlook. Their investment approach is driven by a clear-eyed pragmatism coupled with visionary portfolio optimization practices. They emphasize environmental innovation and responsible investment, believing that these principles lead to value creation and maximum profitability. OIC's strategy involves partnering with midsized private companies and family-owned businesses to support the deployment of sustainable infrastructure and technologies, positioning themselves as collaborative partners committed to the long-term success of their portfolio companies and the advancement of a sustainable future.

Middle Market Companies, Growth StageInfrastructureEnergy

Orkila Capital

EU
O

Orkila Capital was formed in 2013 to pursue proprietary and compelling growth equity investment opportunities in the media, entertainment and consumer sectors. With over 20 years of experience, the principals of Orkila seek to leverage their deep industry knowledge and relationships to focus on growth platforms with differentiated brands, IP, assets or content. They aim to invest in the future of iconic brands.

Growth equitymediaentertainment

Osney Capital

GB

Osney Capital is a sector specialist venture capital firm focused exclusively on early-stage cybersecurity companies in the UK. Their core strategy revolves around identifying and supporting UK cyber founders during the critical early phases of their growth. They aim to add unique value by leveraging their deep sector expertise and network, focusing their investments where they believe their team can significantly impact the company's success. They aim to specialize in early-stage ventures, providing the resources and knowledge needed to scale effectively. Osney Capital aims to create a supportive environment for its portfolio companies by combining financial investment with strategic guidance and operational support. Their value proposition extends beyond just capital; they strive to be a trusted partner, navigating the complexities of the cybersecurity market with their portfolio companies. The firm appears to have cultivated strong relationships with innovation leaders within the UK cyber ecosystem, working with entities such as NSSIF, Cyber Runway by Plexal, HMGCC CoCreation, UKC3, and Cyber ASAP. Osney Capital also demonstrates a commitment to diversity and inclusion through its participation in the Investing in Women Code. By supporting female entrepreneurship in the UK, the firm aims to contribute to a more diverse and inclusive business ecosystem, recognizing the value it brings to customers, entrepreneurs, businesses, investors, and society. This commitment aligns with the firm's broader objective of fostering innovation and growth within the UK cybersecurity sector. Osney Capital appears to be an active player in the venture capital landscape, offering a Venture Capital Internship Program to cultivate talent and provide opportunities for individuals from non-VC backgrounds to gain hands-on experience. This initiative reinforces their commitment to supporting the wider venture capital community and fostering the next generation of investors.

Early-stage, SeedCybersecurity

Ouest Croissance

FR

Ouest Croissance focuses on supporting the development and transmission of SMEs and mid-sized companies (ETI) within the real economy, particularly in regional territories. Their approach involves financial investment and active support at key stages of the company's lifecycle, from growth and transformation to succession planning. They aim to multiply performance by understanding the specific challenges and opportunities of each company and sector. A core component of their investment strategy is incorporating ESG (Environment, Social, and Governance) considerations into their investment decisions and support of portfolio companies.

Development, Transformation, Transmission (implies growth and potentially later stages)TechnologiesMedia

Owl Ventures

US

Owl Ventures is a global venture capital firm focused on investing in transformative learning and workforce AI companies across all stages and sectors. The firm believes education is the most powerful driver of human potential and aims to scale the world's most impactful education companies. They have a decade-long focus on EdTech and aim to not just invest but to build the market, scaling companies from pre-revenue to nine-figure businesses and coordinating M&A across their portfolio. Owl Ventures also prioritizes investments that create lasting change by expanding opportunity, driving equity, and advancing lifelong learning. The firm operates as a full-lifecycle partner, leading rounds from pre-seed through IPO and actively engaging throughout the growth cycle. They leverage their global LP network to gain access to global growth opportunities in education, workforce, and AI-driven learning, with investments spanning six continents. Their extensive portfolio of over 100 companies creates powerful synergies in distribution, talent, M&A, and insights, resulting in a network effect that benefits their portfolio companies. Owl Ventures is focused on backing bold ideas in education and work globally. They invest in companies at every stage, from pre-seed to pre-IPO, to help scale companies from their first customers to becoming global category leaders. Their portfolio spans the full learning journey, from PreK-12 and higher education to workforce development and lifelong learning, with a particular emphasis on AI-powered solutions that are reshaping how knowledge is created, shared, and scaled.

Pre-seed, Seed, Series A, Growth, Pre-IPOEdTechEducation Technology

Oxford Capital

Oxford, GB

Oxford Capital is a venture capital firm based in Oxford, UK, that invests in early-stage and growth-stage companies across the UK. They focus on backing founders of innovative companies with disruptive potential, investing from pre-seed to growth and beyond. With over 25 years of experience, they have invested over £500m into over 100 companies. The firm provides individuals, families, and institutions the ability to participate in these investment opportunities. Oxford Capital aims to bridge the gap between entrepreneurs and private capital investors. The firm's strategy involves supporting companies from their earliest stages to later growth, enabling entrepreneurial successes. They are particularly interested in companies leveraging technology and science to solve complex problems. The firm's investment approach emphasizes backing companies that are creating new markets or disrupting existing ones. Oxford Capital looks for founders with a clear vision, strong execution capabilities, and the potential to build large, scalable businesses. They also focus on providing value beyond capital, offering support in areas such as strategy, operations, and fundraising. Oxford Capital actively monitors the venture capital landscape, providing commentary on industry trends and investment policy through its news and views section. They support the Enterprise Investment Scheme (EIS) as a means to encourage investment in early-stage companies. The firm has a strong emphasis on governance and sustainability in both mature and high-growth companies.

Pre-seed, Seed, Series A, GrowthTechnologyScience

Oxford Technology

Oxford, GB

Oxford Technology specializes in investing in startup and early-stage technology companies based in and around Oxford, UK. Their investment strategy centers around leveraging SEIS and EIS tax reliefs to provide seed and follow-on funding to innovative tech ventures. They manage two funds: a flagship three-year combined SEIS and EIS fund and a Knowledge-Intensive EIS fund, each with slightly different risk/return profiles. The SEIS fund targets earlier-stage companies, investing a portion of the capital upfront and following on with high performers in subsequent years. The Knowledge-Intensive EIS fund focuses on companies already in their portfolio, offering a potentially lower risk/return profile. The firm typically invests up to £150k of seed funding into SEIS-eligible companies and up to £300k of EIS follow-on funding. They emphasize the importance of follow-on investments for achieving the best returns and exit multiples. Oxford Technology also runs WOTAN (Wider Oxford Technology Angel Network) to provide further investment opportunities. The firm prioritizes investments in companies with novel science or technology that can disrupt existing sectors or create new ones. They seek companies that are SEIS-eligible, especially those located in or around Oxford. Oxford Technology's investment approach includes tax relief benefits for investors under SEIS and EIS schemes. They provide investors with opportunities to participate in monthly presentations of follow-on EIS-eligible pitches. They also actively assist portfolio companies in their early years, especially those located near Oxford. Their investment philosophy is oriented towards providing both capital growth and tax reliefs.

Seed, Early Stage, Follow-on (EIS)TechnologyScience

Oxford Technology Management

Oxford, GB

Oxford Technology Management specializes in investing in startup and early-stage technology companies based in and around Oxford since 1983. The firm leverages the UK's SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) tax reliefs to provide investors with tax-efficient access to innovative technology startups. Their investment strategy focuses on providing seed funding to SEIS-eligible companies and follow-on EIS funding to high-performing ventures within their portfolio. The firm believes that the ability to make follow-on investments is crucial for achieving the best returns and highest exit multiples. Oxford Technology manages two funds: a flagship three-year combined SEIS and EIS fund, and an approved Knowledge-Intensive EIS fund. The SEIS and EIS Start-Up Fund invests in approximately eight tech startups over three tax years, allocating a third of the subscription to SEIS companies in the first year and providing follow-on EIS funding in subsequent years. The Knowledge-Intensive EIS Fund invests in five select EIS companies already within the Oxford Technology portfolio, offering a slightly lower risk/return profile due to the companies' progression and higher valuations. The firm emphasizes the benefits of capital growth and tax reliefs associated with SEIS and EIS investments, including income tax reduction, capital gains relief, and tax-free capital gains after three years. Oxford Technology aims to provide investors with opportunities for significant capital growth while mitigating risk through tax advantages and downside protection offered by the schemes. Oxford Technology also operates WOTAN – Wider Oxford Technology Angel Network, connecting investors with early-stage technology opportunities. They host monthly investor presentations featuring follow-on EIS-eligible pitches, further facilitating investment in promising startups.

Seed, Early StageTechnology startupsearly-stage technology companies

PFM Health Sciences

CA

PFM Health Sciences, founded in 2004, operates as a healthcare investment advisor managing both public and private investments. The firm is led by Founding Partner and CIO, Brian Grossman. Their investment thesis centers on a powerful, secular healthcare innovation cycle presenting transformative investment opportunities. They believe a specialist, bottom-up, fundamental approach is well-suited to the healthcare sector, capitalizing on secular growth, domain expertise, and demographic trends. PFM Health Sciences emphasizes partnering with companies that demonstrate a measurable and sustainable impact on health outcomes, alongside responsible stewardship of institutional capital. Their approach to risk management and portfolio construction aims to dampen volatility while providing an attractive return/risk profile. A core tenet is the flexibility to invest across the capital structure, engaging with both public and private companies to maximize opportunity. In essence, PFM Health Sciences focuses on identifying and investing in innovative healthcare companies that contribute to positive health outcomes and demonstrate responsible capital management. They leverage a specialized, fundamental approach to navigate the complexities of the healthcare sector, employing a flexible investment strategy that spans public and private markets.

public and private investmentsbiopharmamedical technology

PFR Ventures

Warsaw, PL

PFR Ventures is the largest Fund of Funds manager in Central and Eastern Europe, focused on supporting the development of the domestic Venture Capital and Private Equity market. They invest in VC funds that, in turn, invest in innovative companies. Their strategy involves allocating capital to various VC funds, including those specializing in deep tech, and participating in initiatives like Innovate Poland to further stimulate investment in Polish companies. The firm aims to catalyze the growth of the Polish innovation ecosystem by providing capital and expertise to promising ventures through fund investments.

Early Stage, Late StageVenture CapitalPrivate Equity